SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Acadia Healthcare Company, Inc. (NASDAQ: ACHC), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under the federal securities laws.
What if I purchased Acadia Healthcare common stock? If you purchased securities in the company and suffered losses on your investment, join our investigation now: https://www.johnsonfistel.com/investigations/acadia-healthcare
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471
There is no cost or obligation to you.
What is Johnson Fistel investigating? Acadia Healthcare, on September 26, 2024, consented to a settlement of $19.85 million to address allegations asserting that the company submitted claims for medically unnecessary inpatient behavioral health services, the U.S. Justice Department announced. Of this settlement, $16.66 million will be disbursed to the U.S. government to resolve accusations of fraudulent billing under federal health programs, and an additional $3.19 million will be allocated to the states of Florida, Georgia, Michigan, and Nevada to settle claims under respective state laws.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com
